Home Blog Page 3919

Visionary Enters the New Energy Vehicle Field with Eyes on the Global Market

TORONTO, March 3, 2025 /PRNewswire/ — Recently, Visionary Holdings Inc. (hereinafter referred to as “Visionary”, NASDAQ stock code: GV), a technology enterprise listed on the NASDAQ Capital Market, announced that after years of research and development, PEGASUS New Energy Vehicles under Visionary were officially launched in 2025. The company aims to create “PEGASUS”, the No. 1 brand in the automotive industry ecosystem of an independently developed brand in Canada, which has attracted great attention from the capital market.

Against the backdrop of increasingly strict environmental protection regulations and tightening carbon emission indicators, the global new energy vehicle market is showing a trend of rapid growth. In 2023, the sales volume of new energy passenger vehicles in Europe soared, with the annual growth rate far exceeding expectations; the sales volume of new energy vehicles in the United States also reached a new high, indicating huge market potential. Visionary has keenly captured this market opportunity. With its strong technical accumulation and powerful global resource integration capabilities, it has entered the market with great momentum and is expected to stand out in the highly competitive new energy vehicle market.

It is understood that Visionary will adopt a cross-ocean collaborative industrial model. It will achieve localization of vehicle model research and development, design, assembly production, sales, and after-sales service in Canada. At the same time, it will make full use of the advantages of the global automotive parts industry, especially the automotive parts industry in China, and entrust global partner factories to process the production of automotive parts. This model can not only reduce production costs but also improve production efficiency, giving the enterprise an edge in market competition.

In terms of product planning, Visionary will initially launch two core vehicle models: one is a compact intelligent electric sedan targeting young urban commuters, with a cruising range of 400-500 kilometers, equipped with an intelligent interactive cockpit and advanced automatic driving assistance functions; the other is a medium-sized luxury electric SUV that meets the needs of family travel and business reception, with a cruising range of 500-600 kilometers, boasting a luxurious and comfortable driving space and high-end configurations. In the later stage, pickup trucks, heavy-duty truck logistics models, and urban special-purpose vehicle models will be successively launched. In addition, Visionary will cooperate with global leading battery suppliers and introduce high-energy-density solid-state battery technology, achieving the excellent performance of charging from 10% to 80% in just 10 minutes, bringing consumers a better user experience.

In order to enhance brand awareness and market share, Visionary has formulated a comprehensive marketing strategy. It will actively participate in top auto shows in Europe and the United States, plan to invite international superstars as brand ambassadors, and conduct word-of-mouth promotion through social media and automotive forums. At the same time, it will set up brand direct sales experience stores and after-sales service centers in core cities around the world, cooperate with local large-scale dealer groups, and build an official online store and flagship stores on e-commerce platforms to achieve integrated online and offline development.

In terms of production and operation, Visionary will rely on the mature global automotive parts industry clusters, entrust top global factories for processing, and cultivate local suppliers in Canada. The localization rate of automotive parts will reach more than 40%. In particular, it will maintain core local research and development advantages in the three-electric system and intelligent driving system of new energy vehicles to reduce supply risks. During the production process, it will fully adopt the Industry 4.0 flexible production line, with an automation rate of up to 85%, ensuring efficient and accurate production capacity output. Visionary will also strictly follow the quality standards of the automotive industry in Europe and the United States and establish a complete quality control system to ensure the reliability and durability of its products.

The financial plan shows that Visionary has made a reasonable capital layout in aspects such as factory construction, equipment procurement, technology research and development, and market promotion, and has made an optimistic outlook on future earnings. In the first year after the project is put into production, the production capacity is expected to reach 100,000 vehicles, and the sales revenue is expected to reach 4 billion US dollars. The subsequent annual sales growth rate is expected to exceed 30%. In the fifth year, it is expected to achieve a revenue of 15 billion US dollars, a net profit of about 1.5-2 billion US dollars, a net profit margin of 10%-15%, an internal rate of return of over 20%, and an investment payback period of about 3-4 years.

Facing risks such as technological iteration and market fluctuations, Visionary said that it will increase investment in research and development, cooperate with universities and scientific research institutions to maintain a leading position in technology; at the same time, it will establish a market dynamic monitoring mechanism, flexibly adjust production plans and marketing strategies, and use financial instruments to lock in raw material costs to ensure the stable development of the enterprise.

Analysts believe that Visionary’s active layout in the new energy vehicle field not only conforms to the development trend of the industry but also will bring new performance growth points to Visionary. With the gradual progress of the project, it is expected to increase Visionary’s market valuation and bring generous returns to investors. The launch of Visionary’s “PEGASUS” new energy vehicle project undoubtedly injects new vitality into the global new energy mobility field and is worthy of market expectation.

For more information, please contact:

Visionary Holdings Inc.
Investor Relations Department
Email: ir@farvision.ca

Addentax Group Corp. Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

SHENZHEN, China, March 3, 2025 /PRNewswire/ — Addentax Group Corp. (“Addentax” or the “Company”) (Nasdaq: ATXG) announced that it has regained compliance with the Nasdaq Listing Rule 5450(a)(1).

On April 24, 2024, the Company was notified by Nasdaq that its common stock had failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days, as required by Nasdaq Listing Rules. However, Nasdaq has now confirmed that for the 10 consecutive business days from February 7 through February 21, 2025, the closing bid price of the Company’s common stock has been at or above $1.00 per share. As a result, the Company has regained compliance, and this matter is now closed.

About Addentax Group Corp.

Addentax Group Corp. is an integrated service provider specializing in garment manufacturing, logistics services, and property management and subleasing. For more information about the Company, please visit the website: https://www.addentax.com/.

Caution Concerning Forward Looking Statements

All statements other than statements of historical fact in this announcement are forward-looking statements in nature within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions are intended to identify such forward-looking statements. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to consider risk factors, including those described in the Company’s filings with the SEC, that may affect the Company’s future results. All forward-looking statements attributable to the Company and its subsidiaries or persons acting on their behalf are expressly qualified in their entirety by these risk factors. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. These forward-looking statements are based on information currently available to Addentax and its current plans or expectations and are subject to a number of known and unknown uncertainties, risks and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These and other important factors are described in detail in the “Risk Factors” section of Addentax’s Annual Report on Form 10-K for the year ended March 31, 2023. Although we believe the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

Company Contact:

Public Relations Contact:
Addentax Group Corp. Corp.
Phone: + (86) 755 86961 405
xinyee.lee@zgyingxi.com

Investor Relations Contact:

Sherry Zheng
WAVECREST GROUP INC.
1-718-213-7386

SunCar Partners with Visa to Empower ICBC Cardholder Benefits in China’s Affluent Consumer Market

NEW YORK, March 3, 2025 /PRNewswire/ — SunCar Technology Group Inc. (“SunCar” or the “Company”) (NASDAQ: SDA), an innovative leader in auto e-insurance and cloud-based B2B auto services in China, today announced its selection as the exclusive provider for the Visa Concierge Car Service Project, establishing a pivotal partnership with global payments leader Visa. This strategic alliance positions SunCar to deliver premium airport and high-speed rail transfer services to Industrial and Commercial Bank of China’s (ICBC) high-net-worth cardholders nationwide, opening significant new revenue channels in China’s lucrative premium services market.

This partnership represents a substantial expansion of SunCar’s addressable market, providing direct access to ICBC’s coveted Platinum and Black Gold cardholders—an elite customer segment with individual assets exceeding $1.1 million and credit card spending limits above $275,000.

“Securing this partnership with Visa, following their rigorous vendor evaluation process, validates our technology platform’s superiority and service excellence,” said Ye Zaichang, CEO of SunCar. “This high-profile collaboration enhances our market position with minimal additional capital expenditure, accelerating our path to increased shareholder value.”

The exclusive partnership leverages SunCar’s established nationwide service network and proprietary cloud-based technology platform, allowing for rapid scaling with limited incremental costs. The company’s advanced AI-powered dispatch system ensures optimal resource allocation, maintaining premium service levels while maximizing operational efficiency across China’s first-tier and emerging city markets.

China’s premium services market continues to expand alongside the country’s growing high-net-worth population, presenting substantial growth opportunities for well-positioned service providers.

About SunCar Technology Group Inc.

Founded in 2007, SunCar is transforming the customer journey for auto services and auto insurance in China, the largest passenger vehicle market in the world. SunCar develops and operates cloud-based platforms that seamlessly connect drivers with a wide range of auto services and insurance coverage options through a nationwide network of sales partners. As a result, SunCar has established itself as the leader in China in the B2B auto services market and the auto eInsurance market for electric vehicles. The Company’s intelligent cloud platform empowers its enterprise clients to access and manage their customer database and offerings optimally, and drivers gain access to hundreds of services from tens of thousands of independent providers in a single application. For more information, please visit: https://suncartech.com. 

Forward-Looking Statements

This press release contains information about the Company’s view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. The Company encourages you to review other factors that may affect its future results in the Company’s annual reports and in its other filings with the Securities and Exchange Commission.

Contact Information:

SunCar:
Investor Relations: Ms. Hui Jiang
Email: IR@suncartech.com
Legal: Ms. Li Chen
Email: chenli@suncartech.com 

U.S. Investor Relations
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com 

ESR Unveils Upgraded Digital Presence Reflecting Its Focus on Innovation and Technology

Transformation from ESR Gear to ESR Tech further advances the mission of “Tech Made Easier”, enhancing everyday tech experiences with innovative solutions

WILMINGTON, Del., March 3, 2025 /PRNewswire/ — ESR, a global leader in tech accessories with over 100 million users worldwide, is proud to announce a major milestone in its brand journey, including a new website and enhanced digital experience. This strategic upgrade underscores ESR’s commitment to innovation, user-centric solutions, and its ongoing evolution to elevate everyday tech experiences with greater efficiency and convenience.

ESR Unveils Upgraded Digital Presence Reflecting Its Focus on Innovation and Technology
ESR Unveils Upgraded Digital Presence Reflecting Its Focus on Innovation and Technology

“The transformation from ESR Gear to ESR Tech marks a pivotal step in our brand journey,” said Tim Wu, ESR’s CEO. “This change reflects our deeper focus on innovation and enriching users’ lives through Tech Made Easier. We are dedicated to simplifying and enhancing tech experiences, expanding our range of world-first products and cutting-edge solutions that empower users by fostering creativity, productivity, and connectivity in all aspects of their daily lives.”

ESR has established itself as a leader in the tech industry, developing a wide range of first-of-their-kind products that combine award-winning design with unmatched functionality. Inspired by Apple’s MagSafe technology in 2020, ESR pioneered innovations in the MagSafe space with its HaloLock ecosystem and CryoBoost™ technology, delivering versatile, easy-to-use products that enhance user convenience. In 2023, ESR expanded its involvement in the Apple ecosystem beyond MagSafe charging with its Geo series that utilizes Find My tracking to redefine the concept of everyday carry. This progress stems from the company’s substantial investment in research and development, leading to an impressive portfolio of over 490 patents to date.

Looking ahead, ESR will continue to explore the possibilities of mobile technology, broadening its product portfolio and global impact, while delivering products and solutions from protection to charging to productivity across a variety of scenarios in users’ everyday lives. As always, ESR will set the standard for seamlessly integrating technology solutions, transforming user experiences, and making technology easier to use.

Key Updates in ESR’s Digital Transformation:

To accompany this transformation, ESR is launching an upgraded website and digital presence, providing users with an improved, seamless experience.

  • New Website & Domain: ESR has moved to www.esrtech.com, offering a more intuitive shopping experience and easier access to the latest products and updates. The previous domain, www.esrgear.com, is no longer in use.
  • Enhanced Website Features:
    • Improved Performance: Pages load 20% faster for a smoother experience.
    • Streamlined Navigation: Simplified interfaces make exploring ESR’s product range easier and more user-friendly.
    • Advanced After-Sales Options: Customers can access automated order cancellations and refunds.
  • Revitalized Social Media: ESR’s updated social platforms deliver timely product updates, giveaways, exclusive offers, and enhanced engagement.
  • New Packaging: ESR has updated its packaging. Products may arrive in either old or new packaging during the transition, but the quality remains consistent.

Celebrating with Exclusive Rewards

To celebrate this milestone, ESR is offering special rewards to express its appreciation for users’ continued support and trust:

  • Returning Users: Log in to receive 20% off your next purchase with no minimum spend required.
  • All Users: Enjoy 15% off with the code “NWESR” automatically applied at checkout.

About ESR: Trusted for 16 Years

Founded in 2009, and now with a user base of over 100 million people worldwide, ESR is a leading brand of mobile accessories and the #1 brand for MagSafe accessories. From cases that do more than protect to wireless chargers that reimagine what’s possible with MagSafe, we’re on a mission to make tech easier to use. To stay updated on the latest news and product launches around ESR, please visit www.esrtech.com or follow ESR’s social media on X, Instagram, and Facebook.

ZekoAI: Powering Private, Decentralized, and Automated Artificial Intelligence Workflows

SAN FRANCISCO, March 3, 2025 /PRNewswire/ — The convergence of artificial intelligence, zero-knowledge, and decentralized finance represents a transformative frontier in blockchain technology. By combining Zeko’s zero-knowledge protocol, with Shinkai’s AI agents, and Lumina’s decentralized exchange capabilities, developers can create sophisticated, privacy-preserving automated transaction workflows that redefine blockchain computational efficiency and data protection.

The convergence of artificial intelligence, zero-knowledge, and decentralized finance represents a transformative frontier in blockchain technology. By combining Zeko’s zero-knowledge protocol, with Shinkai’s automated AI agents, and Lumina’s decentralized exchange capabilities, developers can create sophisticated, privacy-preserving automated transaction workflows that redefine blockchain computational efficiency and data protection.
The convergence of artificial intelligence, zero-knowledge, and decentralized finance represents a transformative frontier in blockchain technology. By combining Zeko’s zero-knowledge protocol, with Shinkai’s automated AI agents, and Lumina’s decentralized exchange capabilities, developers can create sophisticated, privacy-preserving automated transaction workflows that redefine blockchain computational efficiency and data protection.

New Decentralized AI Use-Cases

Zeko (https://zeko.io/) is excited to announce ZekoAI, a brand new way to programmatically create decentralized AI agents, in partnership with Shinkai (https://www.shinkai.com/). This integration delivers remarkable advantages for developers and companies building decentralized, autonomous AI solutions powered by zero-knowledge technology. By executing computations privately and generating verifiable proofs, the system achieves an optimal balance between confidentiality and transparency. The off-chain processing dramatically reduces computational overhead and cost, while the zero-knowledge proofs ensure easy verifiability by independent parties.

The AI agents built by Shinkai introduce a layer of adaptive intelligence that can dynamically optimize workflows, assess market conditions, and execute strategies with minimal human intervention. The initial integration with Lumina’s decentralized exchange protocol (https://luminadex.com/) opens up possibilities for more sophisticated AI financial operations, including:

  • Advanced algorithmic trading strategies
  • Liquidity provision optimization
  • Cross-protocol asset management
  • Complex financial instrument interactions
  • Executing off-chain limit orders on centralized exchanges
  • New unsecured credit and reputation protocols

Conclusion

The convergence of Zeko’s zero-knowledge technology, Shinkai AI agents, and Lumina’s exchange infrastructure represents a significant advancement in blockchain paradigms.

Developers and financial engineers stand at the precipice of a new era of blockchain computation—one that prioritizes privacy, intelligence, verifiable integrity, and automation. As these technologies continue to evolve, we can anticipate increasingly sophisticated approaches to decentralized AI workflows.

 

Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept

  • Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird Bioscience
  • Financing led by Frazier Life Sciences with significant participation from Jeito Capital alongside other life sciences investors including Novo Holdings A/S, Omega Funds, ClavystBio, Platanus, Norwest, Pureos Bioventures, SEEDS Capital and EDBI
  • Company to advance innovative multi-payload programs designed to maximize therapeutic benefit for cancer patients by overcoming limitations of existing single-payload therapies

SEATTLE and SINGAPORE, March 3, 2025 /PRNewswire/ — Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, today announced its launch with the closing of a $187.0 million Series A financing round. This financing was led by Frazier Life Sciences with significant participation from Jeito Capital alongside other life sciences investors, including Novo Holdings A/S, Omega Funds, ClavystBio, Platanus, Norwest, Pureos Bioventures, SEEDS Capital and EDBI. The newly formed company, with headquarters in Seattle and Singapore, intends to use the proceeds from the Series A financing to achieve clinical proof-of-concept for its HER2-targeted dual-payload ADC and a second undisclosed ADC program.

In conjunction with the financing, Callio Therapeutics has entered into an exclusive worldwide license agreement with Hummingbird Bioscience for its multi-payload ADC platform in oncology, and associated intellectual property and pipeline assets, in exchange for equity, potential milestone payments and royalties.

“We are delighted to be launching Callio Therapeutics with the support of Frazier Life Sciences and this syndicate of investors. Multi-payload ADCs have the potential to enable the targeted delivery of rational drug combinations to cancer cells, and may provide significantly enhanced efficacy,” said Piers Ingram, PhD, co-founder and Chief Executive Officer of Callio Therapeutics. “This new generation of ADC therapies may meaningfully improve outcomes for patients.”  

Leadership Team

The founding Callio Therapeutics management team comprises individuals with extensive experience from leading biotechnology and biopharmaceutical companies including ProfoundBio, Silverback Therapeutics, SeaGen, Medarex, Hummingbird Bioscience and Genentech:

  • Piers Ingram, PhD, Chief Executive Officer
  • Jerome Boyd-Kirkup, PhD, Chief Scientific Officer
  • Naomi Hunder, MD, Chief Medical Officer
  • Angèle Maki, PhD, Chief Business Officer

“The multi-payload ADCs being developed at Callio Therapeutics have the potential to address large unmet medical needs by overcoming many of the limitations of existing ADCs,” said Adam Simpson, Executive Board Chair of Callio Therapeutics and Venture Partner at Frazier Life Sciences. “With the expertise of the Callio Therapeutics team, together with access to the innovative multi-payload ADC technology, we believe that Callio Therapeutics will be the first company to show the clinical benefit of this exciting new multi-payload ADC approach and is well positioned to transform cancer therapy.”

About Callio Therapeutics
Headquartered in Seattle and Singapore, Callio Therapeutics is focused on realizing the promise of multi-payload antibody-drug conjugates to transform cancer patient outcomes. The company is developing next-generation, multi-payload antibody-drug conjugates (ADCs) that feature differentiated payload and linker technologies that enable targeted delivery of multi agents to tumor cells to maximize therapeutic benefit. Callio Therapeutics’ lead program is a HER2-targeted dual-payload ADC. Callio Therapeutics was created by Frazier Life Sciences, a longstanding investment firm focused on innovative therapeutics, based on ADC technology and programs exclusively in-licensed from Hummingbird Bioscience. For more information, please visit www.calliotx.com and follow Callio Therapeutics on LinkedIn.

About Frazier Life Sciences
Frazier Life Sciences invests globally in private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals. Frazier Life Sciences manages over $3.9 billion in capital, including Venture Funds focusing on company creation and private companies and the long-only Public Fund focused on small and mid-cap public companies. Since 2005, over 60 Frazier Life Sciences portfolio companies, many of which were created or seeded by Frazier Life Sciences, have completed IPOs or M&As. The Frazier Life Sciences team consists of over 40 professionals with deep expertise in biopharmaceuticals, primarily located in Palo Alto, Calif. (headquarters), San Diego, Seattle, Boston, New York and London. For more information about Frazier Life Sciences, please visit frazierls.com and follow on LinkedIn.

About Hummingbird Bioscience
Hummingbird Bioscience is a Singapore-based biotherapeutics company working at the interface of artificial intelligence and human innovation to discover and develop transformative medicines for hard-to-treat diseases. Hummingbird Bioscience’s computational and systems biology technologies have generated a pipeline of innovative clinical-stage monoclonal antibodies and antibody-drug conjugates in oncology and autoimmunity.  At Hummingbird Bioscience, the commitment to rigorous science, teamwork, and intellectual integrity underpins our passion to accelerate the journey of new drugs from concept to clinic. For more information, please visit www.hummingbirdbioscience.com, and follow Hummingbird Bioscience on LinkedIn, X (formerly Twitter), and YouTube.

KPM Analytics Secures Legal Victory in Trade Secret Misappropriation Case

Court awards $10M to KPM Analytics in Trade Secret Theft and Tortious Interference Case, Reinforcing Commitment to Innovation and Fair Competition.

WESTBOROUGH, Mass., March 3, 2025 /PRNewswire/ — KPM Analytics, a global leader in analytical instrumentation for food and agriculture industries, has been awarded damages, attorney fees, and interest, totaling just over $10 million in a decisive legal victory against Blue Sun Scientific, LLC, the Innovative Technologies Group & Co., Ltd., and certain ex-KPM employees. In addition to the awarded monetary damages, the United States District Court for the District of Massachusetts also granted KPM Analytics’ requests for a permanent injunction against the defendants, including Blue Sun Scientific, LLC, prohibiting the defendants from offering to sell certain NIR products, services, hardware, software, or data to customers.

The 11-day trial of KPM Analytics North America Corporation vs. Blue Sun Scientific, LLC, The Innovative Technologies Group & Co., Ltd., Arnold Eilert, Robert Gajewski, Rachael Glenister, and Irvin Lucas (Civil Action No. 21-CV-10572-MRG), which concluded with a unanimous verdict on 6 counts of the Complaint against the defendants on May 17, 2023, stemmed from allegations that the defendants willfully and maliciously misappropriated confidential information and trade secrets concerning KPM Analytics near infrared (NIR) technologies. As a result, the court awarded exemplary damages, doubling the compensatory damages against certain defendants. 

“This verdict is not just a win for KPM Analytics but for the entire industry,” said Brian Mitchell, Chief Executive Officer for KPM Analytics. “Innovation is the backbone of our business, and we will always take the necessary steps to protect our proprietary technology from unlawful use.”

KPM would like to extend its gratitude to the dedicated legal team, Sunstein LLP and Morse Barnes-Brown & Pendleton, PC, expert witnesses, and all those involved in the two-year long case, whose unwavering support and diligent efforts were instrumental in achieving this significant victory. The verdict serves as a reminder that KPM will not tolerate the misappropriation of its trade secrets and will take all necessary legal measures to safeguard its valuable intellectual property.

About KPM Analytics

KPM Analytics is a global leader in scientific instrumentation and vision process machinery, focused primarily on analyzing critical parameters within the food, feed, agriculture, and environmental sectors. We provide a comprehensive range of products and services to uniquely solve our customers’ problems. Our brands include AMS Alliance, Bruins Instruments, CHOPIN Technologies, EyePro System, Process Sensors, Sensortech, Sightline, Smart Vision Works, and Unity Scientific. Each has a long history of delivering advanced and reliable analysis solutions to ensure product quality and optimize process efficiency, with customer service at the center of everything we do. Visit www.kpmanalytics.com to learn more.

Media contacts:

Andy Dambeck

Marketing Manager

adambeck@kpmanalytics.com

774-399-0477

 

Frost & Sullivan Recognizes Cynerio for Advancing Healthcare Cybersecurity with Its NDR-H Solution to Combat Cyber Threats

Cynerio’s NDR-H Solution enables deep packet inspection, comprehensive network traffic analysis with real-time threat detection and response, and proactive auto identification and analysis of connected devices.

SAN ANTONIO, March 3, 2025 /PRNewswire/ — Frost & Sullivan recently analyzed the healthcare security industry and, based on its assessment, recognizes Cynerio with the 2025 North American Enabling Technology Leadership Award. Realizing just how extensive healthcare cybersecurity challenges are for organizations beginning to build out their security programs, the company offers customers a single platform composed of three core offerings to meet the most prevalent organizational needs. Cynerio has devoted critical investment and development time to the deep packet inspection capabilities of its technical appliance. These efforts have been key to developing its Healthcare Cybersecurity Platform over the past six years. Cynerio’s Network Detection and Response for Healthcare (NDR-H) solution provides comprehensive network traffic analysis with real-time threat detection and response capabilities against the most common attack vectors. These include ransomware, malware, and common breach patterns that have been observed or reported by other healthcare entities as part of threat intelligence and collaboration initiatives.

Cynerio’s Medical Device Security solution offers proactive automatic identification and analysis of the connected devices present in the organization’s network to determine the optimal utilization and security of these assets. The solution also includes mitigation recommendations or best practices that can be enacted, such as micro-segmentation guidance, patch recommendations, or new use cases, to improve an asset’s overall efficiency. In doing so, the solution offers both security and organizational guidance. The company’s Complete Asset Visibility solution provides a single pane of glass view of all the connected technologies within the organization, including IT, operational technologies (OT), IoT, and Internet of Medical Things (IoMT) assets.

Danielle VanZandt, research manager for security at Frost & Sullivan, observed, “Cynerio’s multi-faceted platform aligns well with the triage-centric operational methodology that is fundamental to the healthcare industry, enabling security teams to efficiently determine the most prescient mitigation actions and better prioritize security objectives without overwhelming personnel.”

Cynerio’s Healthcare Cybersecurity Platform enables healthcare security teams to gain the visibility they require, determine the current security posture of their connected assets, and enact mitigation measures for improvement while having real-time awareness of the threats targeting them. The NDR-H solution meets industry demands and combats the rising wave of cyberattacks, actively tackling customers’ most pressing security challenges. Cynerio can also accelerate its internal product evolution based on these discussions, identify any new threats or attack vectors as they appear, and deploy an updated platform to customers to defend against the latest threats. Customers trust Cynerio as a knowledgeable and reliable partner that can support the deployment of their healthcare cybersecurity programs and keep them informed on the latest developments through continuous feedback.

“Cynerio has emerged as a key partner for healthcare customers looking to gain visibility into their entire organizational infrastructure, secure an expansive network of connected devices, and actively detect and combat cybersecurity threats as the healthcare sector continues to build out its security standards and best practices. Through the company’s robust Healthcare Cybersecurity Platform, Cynerio offers customers a centralized platform that addresses cybersecurity challenges across the organization, appealing to multiple stakeholders and connecting customers with Cynerio’s subject matter experts who serve as guides through this ever-changing industry,” added Danielle. With its robust cybersecurity platform and robust knowledge of the healthcare cybersecurity ecosystem performance, Cynerio earns Frost & Sullivan’s 2025 North American Enabling Technology Leadership Recognition in the healthcare security industry.

Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products, but also enables the development of new products and applications. The award recognizes the high market acceptance potential of the recipient’s technology.

Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

Access the full Frost & Sullivan 2025 North American Enabling Technology Leadership Report here.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:

Camila Tinajero
P: +54911 6713 2748
E:Camila.Tinajero@frost.com

About Cynerio    

Cynerio empowers healthcare organizations with a comprehensive cybersecurity platform designed to protect medical environments from evolving cyber threats. With real-time threat detection, automated risk mitigation, and strategic micro-segmentation guidance, Cynerio helps hospitals and healthcare providers secure their networks, protect patient data, and ensure the resilience of connected devices. By delivering NDR-H, Medical Device Security, and Complete Asset Visibility, Cynerio provides healthcare security teams with the tools they need to prevent cyberattacks, maintain compliance, and enhance patient safety.

For more information, visit www.cynerio.com